FEATURED PRESENTATIONS

Keynote Presentation: FRIDAY, OCTOBER 31
A Funny Thing Happened on My Way to Chemotherapy
Dan Shapiro, PhD Dan Shapiro, PhD
Penn State College of Medicine

Akin to a one-act play, this talk emphasizes the importance of connecting to others and hope in the face of challenging regimens -- but these messages are embedded in first-person stories that appreciate the complexity of front-line medicine.

Panel Discussion: FRIDAY, OCTOBER 31
Genetics & BRCA Mutations
Sue Friedman, DVM Jacqueline Hale, RN, APN, AOCN®
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP®
University of California San Francisco
Sue Friedman, DVM
FORCE Executive Director
Jacqueline Hale, RN, APN, AOCN®
Hunterdon Health Care
Heather Hampel, MS, LGC Philomena McAndrew, MD William T. McGivney, PhD
Heather Hampel, MS, LGC
The Ohio State University Comprehensive Cancer Center
Philomena McAndrew, MD
Cedars-Sinai, Tower Hematology Oncology Medical Group
William T. McGivney, PhD
McGivney Global Advisors

Awareness of genetic mutations and their effect on the heightened risk of breast cancer is essential in the care of this patient population, and APs need to understand the implications of BRCA-associated cancer as well as the newly identified PALB-2 mutation. This session will address the controversies and challenges in genetic testing for breast cancer, including the social and ethical implications of testing for genetic mutations in this patient population.

Panel Discussion: SATURDAY, NOVEMBER 1
2014 JADPRO Survey Results & APSHO Discussion
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C Christopher J. Campen, PharmD, BCPS, BCOP Heather M. Hylton, MS, PA-C Pamela Hallquist Viale, RN, MS, CS, ANP Wendy H. Vogel, MSN, FNP, AOCNP®
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Arizona Cancer Center
Christopher J. Campen, PharmD, BCPS, BCOP
Arizona Cancer Center
Heather M. Hylton, MS, PA-C
Memorial Sloan Kettering Cancer Center
Pamela Hallquist Viale, RN, MS, CS, ANP
University of California, San Francisco
Wendy H. Vogel, MSN, FNP, AOCNP®
Wellmont Cancer Institute

The role of the Advanced Practitioner in Hematology/Oncology is expanding and the number of APs required to meet the anticipated expansion of the hematology and oncology population is staggering. The Advanced Practitioner Society for Hematology and Oncology is the only organization that represents APs collectively (including nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and advanced degree nurses. In this session, speakers will discuss the goals, mission, and vision for APSHO. In addition, they will review the results of a membership survey for APSHO, which will help describe the AP in oncology and guide programs to support this critical role.

 











APSHO.org Meniscus JADPRO